This website is intended for healthcare professionals only
Specialities

Specialities

Artificial Intelligence
Anterior Segment
Cataract Surgery
Corneal and External Disorders
COVID-19
Diabetic Macular Edema
Diabetic Retinopathy
Glaucoma
Imaging
Macular Degeneration
Neuro-ophthalmology
Ocular Oncology
Ocular Surface Disease
Oculoplastic Surgery
Pediatric Ophthalmology
Refractive Surgery
Retina/Vitreous
Ocular Immunology
Rare Disease Day
Posterior Segment
Search

Trending Topic

Macro shot of eye featuring holographic HUD graphics layered over pupil and cornea, neon light accents and sharp reflections, high tech cyber vision theme, ultra detailed 8k
7 mins

Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Advancing Keratoconus Management: ECO-CAIRS, Biomechanics and the Evolution of Corneal Allogenic Intrastromal Ring Segments

Emilio A Torres-Netto, Mark Hillen, Farhad Hafezi

Corneal ectatic disorders, such as keratoconus, progressively weaken corneal integrity, leading to thinning, irregular astigmatism and visual deterioration.1 Typically progressive in nature, these ectasias result in increasingly thinner corneas, causing the cornea to protrude forward into a cone shape. This leads to increasing amounts of myopia and astigmatism – both regular and irregular – as the disease […]

touchREVIEWS in Ophthalmology. 2026;20(1):1–4:Online ahead of journal publication

Connect With Us:

Facebook
X (Twitter)
Instagram
Youtube
Linkedin

Paisan Ruamviboonsuk, EURETINA 2021: Artificial Intelligence in Ophthalmology

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Sep 20th 2021

It was a pleasure to speak with Paisan Ruamviboonsuk (Rajavithi Hospital, Bangkok, Thailand) about his views on artificial intelligence in ophthalmology, specifically for diagnosis and screening for polypoidal choroidal vasculopathy.

Questions

  1. Could you give us a brief overview of your research in artificial intelligence (AI) in ophthalmology? (00:18)
  2. What is the potential of AI in the diagnosis and screening for polypoidal choroidal vasculopathy (PCV)? (01:13)
  3. What are the major challenges in developing AI-based tools in this application? (03:02)

Speaker Disclosure: Paisan Ruamviboonsuk has no financial or non-financial relationships or activities to declare in relation to this interview.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Lisa Glass.

Filmed in coverage of EURETINA 2021.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied

Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

ARVO 2026: DME data spotlight longer durability, IL-6 inhibition and emerging dual-pathway therapies

Arshad M Khanani, Roger Goldberg, Monica Loevestam-Adrian

At the ARVO 2026 Annual Meeting, DME remained a major focus, with multiple studies exploring how clinicians may extend treatment intervals, improve outcomes in suboptimal responders and target inflammatory pathways beyond VEGF. Across phase 2 and phase 3 trials, as well as real-world observational studies, key themes included long-term durability with faricimab, sustained-delivery approaches, and growing evidence supporting dual-pathway strategies that may help address the heterogeneity of DME in routine practice.

Advertisement

    • Related Videos in Retina/Vitreous

    Latest articles videos and clinical updates - straight to your inbox

    Close Popup